Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 15,800 full-time employees. The company went IPO on 2000-03-27. The firm partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. The company provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. The company is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.
Follow-Up Questions
What is Edwards Lifesciences Corp (EW)'s P/E Ratio?
The P/E ratio of Edwards Lifesciences Corp is 10.2524
Who is the CEO of Edwards Lifesciences Corp?
Mr. Bernard Zovighian is the Chief Executive Officer of Edwards Lifesciences Corp, joining the firm since 2016.
What is the price performance of EW stock?
The current price of EW is $84.01, it has decreased 0.16% in the last trading day.
What are the primary business themes or industries for Edwards Lifesciences Corp?
Edwards Lifesciences Corp belongs to Health Care industry and the sector is Health Care
What is Edwards Lifesciences Corp market cap?
Edwards Lifesciences Corp's current market cap is $49.3B
Is Edwards Lifesciences Corp a buy, sell, or hold?
According to wall street analysts, 33 analysts have made analyst ratings for Edwards Lifesciences Corp, including 10 strong buy, 17 buy, 15 hold, 0 sell, and 10 strong sell
